The Ohio State University Medical Center — Columbus, Ohio

Public research footprint of The Ohio State University Medical Center, compiled from the ClinicalTrials.gov public registry.

189

Registered studies

Active

Recruiting now

122

Completed

Stopped or withdrawn

Most-studied conditions

Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) · Gastroesophageal Reflux Disease (GERD) · Complement 3 Glomerulopathy (C3G) · Diabetes Mellitus, Type 2

Recently updated registry entries

NCT02749071 — An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for… (Terminated)
NCT05360056 — Continuous Glucose Monitoring Following Hospital Discharge (Active Not Recruiting)
NCT06051617 — Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Ohio State University Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.